Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FARTHER: RFA +/- Radiotherapy for Small HCC
NCT03988998Phase 3Unknown
- Sponsor
- Guangxi Medical University
- Start
- Jan 2022
- Primary completion
- Dec 2022
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Guangxi Medical University. Primary endpoint: 2-years recurrence rate. Status: unknown.
Beyond the preview
Go deeper on NCT03988998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03988998.